Statistical analysis revealed that the presence of (CK+/STIM1+/ORAI1–) phenotype significantly related (Spearman’s rho analysis, p = 0.049) with relapse in metastatic prostate cancer patients. This evidence concerns the gene STIM1 and metastatic prostate carcinoma.